The use of isotretinoin in acne

References

• Fogh K, Voorhees JJ, Astrom A. Expression, purification and binding properties of human cellular retinoic acid-binding protein type I and II. Arch Biochem Biophys 1993; 300:751 - 755
   PubMed Web of Science ®Google Scholar
• Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, et al. Retinoic acid receptors and retinoid X receptors:interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 1993; 90:30 - 34
   PubMed Web of Science ®Google Scholar
• Levin AA, Bosakowski T, Kazmer S, Grippo JF. 13-cis retinoic acid does not bind to retinoic acid receptors alpha, beta and gamma. Toxicologist 1992; 12:181
   Google Scholar
• Ott F, Bollag W, Geiger JM. Oral 9-cis-retinoic acid in acne therapy. Dermatology 1996; 193:124 - 126
   PubMed Web of Science ®Google Scholar
• Geiger JM, Hommel L, Harms M, Saurat JH. Oral 13-cis-retinoic acid is superior to 9-cis-retinoic acid in sebosuppression in human beings. J Am Acad Dermatol 1996; 34:513 - 515
   PubMed Web of Science ®Google Scholar
• Tsukada M, Schröder M, Roos TC, Chandraratna RA, Reichert U, Merk HF, et al. 13-cis-retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans-retinoic acid and binding to retinoid acid receptors. J Invest Dermatol 2000; 115:321 - 327
   PubMed Web of Science ®Google Scholar
• Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis-retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermato 2006; 126:2178 - 2189
   PubMed Web of Science ®Google Scholar
• Knutson DD. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and lesions. J Invest Dermatol 1974; 62:228 - 307
   Web of Science ®Google Scholar
• Plewig G, Dressel H, Pfleger M, Michelsen S, Kligman AM. Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne. J Dtsch Dermatol Ges 2004; 2:31 - 45
   PubMedGoogle Scholar
• Dalziel K, Barton S, Marks R. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol 1987; 117:317 - 323
   PubMed Web of Science ®Google Scholar
• Coates P, Adams CA, Cunliffe WJ. Does oral isotretinoin prevent Propionibacterium acnes resistance?. Dermatology 1997; 195:4 - 9
   PubMed Web of Science ®Google Scholar
• Leyden JJ, McGinley KJ. Effect of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res 1982; 272:331 - 337
   PubMed Web of Science ®Google Scholar
• King K, Jones DH, Daltry DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982; 107:583 - 590
   PubMed Web of Science ®Google Scholar
• Seguin-Devaux C, Hanriot D, Dailloux M, Latger-Cannard V, Zannad F, Mertes PM, et al. Retinoic acid amplifies the host response to LPS through increased T lymphocyte numbers and LPS binding protein expression. Mol Cell Endocrinol 2005; 241:67 - 76
   Web of Science ®Google Scholar
• Falcon RH, Lee WL, Shalita AR, Suntharalingam K, Fikrig SM. In vitro effect of isotretinoin on monocyte chemotaxis. J Invest Dermatol 1986; 86:550 - 552
   PubMed Web of Science ®Google Scholar
• Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, et al. Isotretinoin therapy for acne: results of a multicentre dose-response study. J Am Acad Dermatol 1994; 10:490 - 496
   Web of Science ®Google Scholar
• Shalita AR. Acne revisited. Arch Dermatol 1994; 130:363 - 364
   PubMed Web of Science ®Google Scholar
• Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris-10 years later: a safe and successful treatment. Br J Dermatol 1993; 129:292 - 296
   PubMed Web of Science ®Google Scholar
• Azoulay L, Oraichi D, Berard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol 2007; 157:1240 - 1248
   PubMed Web of Science ®Google Scholar
• Leyden JJ. Dermatology 1997; 195:20 - 33
   PubMed Web of Science ®Google Scholar
• Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. JEAD 2006; 20:773 - 776
   Google Scholar
• Jones DH, King K, Miller AJ, Cunliffe WJ. A dose-response study of 13-cis-retinoic acid in acne vulgaris. Br J Dermatol 1983; 108:333 - 343
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194:351 - 357
   PubMed Web of Science ®Google Scholar
• Gollnick H, Cunliffe WJ, Berson D, et al. Management of acne. A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49:S1 - 36
   Web of Science ®Google Scholar
• Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for policies to modify usage. BMJ 1993; 306:555 - 556
   PubMed Web of Science ®Google Scholar
• Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol 1994; 131:331 - 336
   PubMed Web of Science ®Google Scholar
• Goulden V, Clark SM, McGeown C, Cunliffe WJ. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997; 137:106 - 108
   PubMed Web of Science ®Google Scholar
• Dréno B, Bettoli V, Ochsendorf F, Perez-Lopez M, Mobacken H, Degreef H, et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006; 15:565 - 571
   Google Scholar
• O’Brien SC, Lewis J, Cunliffe WJ. The Leeds revised acne grading system. J Dermatolog Treat 1998; 9:215 - 220
   Web of Science ®Google Scholar
• Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17:25 - 32
   PubMed Web of Science ®Google Scholar
• Kellet SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140:273 - 282
   PubMed Web of Science ®Google Scholar
• MacDonald-Hull S, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphophobic acne patient. Clin Exp Dermatol 1991; 16:210 - 211
   PubMed Web of Science ®Google Scholar
• Horne HL, Carmichael AJ. Juvenile nodulocystic acne responding to systemic isotretinoin. Br J Dermatol 1997; 136:796 - 797
   PubMed Web of Science ®Google Scholar
• Clark SM, Cunliffe WJ. The use of isotretinoin in the treatment of acne in children. Br J Dermatol 1995; 133:39
   Google Scholar
• Goulden V, Cunliffe WJ. Post adolescent acne: a review of the clinical features. Br J Dermatol 1997; 136:66 - 70
   PubMed Web of Science ®Google Scholar
• Bunker CB, Rustin MD, Dowd PM. Isotretinoin treatment of severe acne in post-transplant patients taking cyclosporin. J Am Acad Dermatol 1990; 22:613 - 614
   Web of Science ®Google Scholar
• Cunliffe WJ, Stables G. Optimum use of isotretinoin in acne. J Cutan Med Surg 1996; 1:S2-14 - S2-25
   Google Scholar
• Plewig C, Jansen T, Kligman A. Pyoderma faciale-a review and report of 20 additional cases: is it rosacea?. Arch Dermatol 1992; 128:1611 - 1617
   PubMed Web of Science ®Google Scholar
• Karvonen S. Acne fulminans: report of clinical findings and treatment of twenty-four patients. J Am Acad Dermatol 1993; 28:572 - 579
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Marples RR, Mills OH Jr. Gram-negative folliculitis. A complication of antibiotic therapy in acne vulgaris. Br J Dermatol 1973; 88:553 - 558
   Web of Science ®Google Scholar
• Boer J. Hidradenitis suppurativa or acne inversa: a clinicopathological study. Br J Dermatol 1996; 135:721 - 725
   PubMed Web of Science ®Google Scholar
• Chow ETY, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol 1992; 126:415 - 419
   PubMed Web of Science ®Google Scholar
• Ketter TA, Post RM, Worthington K. Treatment of perifolliculitis capitis abscendens et suffodiens with isotretinoin. J Dermatolog Treat 1992; 3:27
   Google Scholar
• Holmes R, Black MM. Steatocystoma multiplex with unusual prominent cysts on the face. Br J Dermatol 1980; 102:711 - 713
   PubMed Web of Science ®Google Scholar
• Colburn WA, Gibson DM, Wiens RE, Hanigan JJ. Food increases the bioavailability of isotretinoin. J Clin Pharmacol 1983; 23:534 - 539
   PubMed Web of Science ®Google Scholar
• Layton AM, Stainforth JM, Cunliffe WJ. Ten years’ experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatolog Treat 1994; 4:S2 - S5
   Google Scholar
• Harms M, Masooye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow up study. Dermatologica 1986; 172:148 - 153
   PubMedGoogle Scholar
• Clark SM, Cunliffe WJ. Acne flare and isotretinoin—incidence and treatment. Br J Dermatol 1995; 133:26
   Google Scholar
• Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthesia. Br J Dermatol 1991; 125:256 - 259
   PubMed Web of Science ®Google Scholar
• Clark SM, Goulden V, Cunliffe WJ. The management of acne patients who respond slowly to oral isotretinoin. Br J Dermatol 1996; 135:20
   PubMed Web of Science ®Google Scholar
• Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995; 55:165 - 168
   PubMed Web of Science ®Google Scholar
• Stern RS. When a uniquely effective drug is teratogenic: the case of isotretinoin. N Engl J Med 1989; 320:1007 - 1009
   PubMed Web of Science ®Google Scholar
• Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link?. J Am Acad Dermatol 2001; 45:S168 - S175
   PubMed Web of Science ®Google Scholar
• Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45:515 - 519
   PubMed Web of Science ®Google Scholar
• Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol 2007; 14:s227 - e233
   PubMedGoogle Scholar
• Azoulay L, Blais L, Koren G, LeLorier J, Bérard A. Isotretinoin and the risk of depression in patients with acne vulgaris: a case crossover study. J Clin Psych 2008; e1 - 7
   Google Scholar
• Williams RE, Doherty VR, Perkins W, Aitchison TC, Mackie RM. Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 1992; 126:362 - 366
   PubMed Web of Science ®Google Scholar
• Griffin JP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React Toxicol Rev 1992; 11:41 - 58
   PubMedGoogle Scholar
• Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology 2002; 204:232 - 235
   PubMed Web of Science ®Google Scholar
• Amichai B, Grunwald MH. Isotretinoin in dermatology. J Dermatolog Treat 2000; 11:219 - 240
   Web of Science ®Google Scholar
• Simpson N. Effect of isotretinoin on the quality of life of patients with acne. Pharmacoeconomics 1994; 6:108 - 113
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, Gray JA, MacDonald-Hull S. Cost effectiveness of isotretinoin. J Dermatolog Treat 1991; 1:285 - 288
   Google Scholar
• Lafarge H, Levy PE. Évaluation économique d’une innovation médica-menteuse: le traitement de l’acne sévère par Roaccutane. J Econ Med 1987; 5:117 - 127
   Google Scholar
• Wishart J, Villiger J. Cost-benefit of isotretinoin (Roaccutane). NZ Med J 1991; 104:193
   PubMedGoogle Scholar
• Lee ML, Cooper A. Isotretinoin: cost-benefit study. Australas J Dermatol 1991; 32:17 - 20
   PubMedGoogle Scholar
• Soria C, Allegue F, Galiana J, Ledo A. Decreased isotretinoin efficacy during acute alcohol intake. Dermatologia 1991; 182:203
   PubMedGoogle Scholar
• Berbis P. Retinoid drug; interactions. Ann Dermatol Venereol 1991; 118:271 - 272
   PubMedGoogle Scholar
• Marsden JR. Effects of isotretinoin on carbamazepine pharmacokinetics. Br J Dermatol 1988; 119:403 - 404
   PubMed Web of Science ®Google Scholar